Advanced search
Publication Cover
Leukemia & Lymphoma Volume 47, 2006 - Issue 11
Submit an article Journal homepage
83
Views
15
CrossRef citations to date
0
Altmetric
Original

Anti-CD19 immunotoxin enhances the activity of chemotherapy in severe combined immunodeficient mice with human pre-B acute lymphoblastic leukemia

Dr L. Herrera Temple University Children's Medical Center, Temple University School of Medicine, Philadelphia, PA, USACorrespondence[email protected]
,
C. Stanciu-Herrera Temple University Children's Medical Center, Temple University School of Medicine, Philadelphia, PA, USA
,
C. Morgan Scott and White Memorial Hospital, Temple, TX, USA
,
V. Ghetie Cancer Immunobiology Center, University of Texas South-western Medical Centre, Dallas, TX, USA
&
E. S. Vitetta Cancer Immunobiology Center, University of Texas South-western Medical Centre, Dallas, TX, USA
Pages 2380-2387 | Received 19 Apr 2006, Accepted 23 May 2006, Published online: 01 Jul 2009

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Stefan K. Barta, Yiyu Zou, John Schindler, Niraj Shenoy, Tushar D. Bhagat, Ulrich Steidl & Amit Verma. (2012) Synergy of sequential administration of a deglycosylated ricin A chain-containing combined anti-CD19 and anti-CD22 immunotoxin (Combotox) and cytarabine in a murine model of advanced acute lymphoblastic leukemia. Leukemia & Lymphoma 53:10, pages 1999-2003.
Read now

Articles from other publishers (14)

David J. Flavell & Sopsamorn U. Flavell. (2022) Plant-Derived Type I Ribosome Inactivating Protein-Based Targeted Toxins: A Review of the Clinical Experience. Toxins 14:8, pages 563.
Crossref
Kinga Panuciak, Mikołaj Margas, Karolina Makowska & Monika Lejman. (2022) Insights into Modern Therapeutic Approaches in Pediatric Acute Leukemias. Cells 11:1, pages 139.
Crossref
Nikolaos Papadantonakis & Anjali S. Advani. (2016) Recent advances and novel treatment paradigms in acute lymphocytic leukemia. Therapeutic Advances in Hematology 7:5, pages 252-269.
Crossref
Ofir Wolach & Richard M. Stone. (2015) Blinatumomab for the Treatment of Philadelphia Chromosome–Negative, Precursor B-cell Acute Lymphoblastic Leukemia. Clinical Cancer Research 21:19, pages 4262-4269.
Crossref
Diying ShenYongmin TangSisi LiWeiqun XuLingyan Zhang. (2014) Successful Construction and Massive Expression of a Novel Anti-CD19 Human-Mouse Chimeric Antibody Hm2E8b. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy 33:4, pages 215-220.
Crossref
WEIQUN XU, LINGYAN ZHANG, YI ZHANG & YONGMIN TANG. (2014) Construction and expression of a human/mouse chimeric CD19 monoclonal antibody: Successful modification of a murine IgM to a chimeric IgG. Experimental and Therapeutic Medicine 7:4, pages 849-854.
Crossref
Amy P.N. Skubitz, Elizabeth P. Taras, Kristin L.M. Boylan, Nate N. Waldron, Seunguk Oh, Angela Panoskaltsis-Mortari & Daniel A. Vallera. (2013) Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression. Gynecologic Oncology 130:3, pages 579-587.
Crossref
Soizic Guihard, Pauline Peyrouze & Meyling H Cheok. (2012) Pharmacogenomic considerations of xenograft mouse models of acute leukemia. Pharmacogenomics 13:15, pages 1759-1772.
Crossref
Alan S. Wayne. 2013. Childhood Leukemias. Childhood Leukemias 563 581 .
Xiao‐Yun Liu, Laurentiu M. Pop, Lydia Tsai, Iliodora V. Pop & Ellen S. Vitetta. (2010) Chimeric, divalent and tetravalent anti‐CD19 monoclonal antibodies with potent in vitro and in vivo antitumor activity against human B‐cell lymphoma and pre‐B acute lymphoblastic leukemia cell lines . International Journal of Cancer 129:2, pages 497-506.
Crossref
Lydia K. Tsai, Laurentiu M. Pop, Xiaoyun Liu & Ellen S. Vitetta. (2011) A Comparison of the Anti-Tumor Effects of a Chimeric versus Murine Anti-CD19 Immunotoxins on Human B Cell Lymphoma and Pre-B Acute Lymphoblastic Leukemia Cell Lines. Toxins 3:4, pages 409-419.
Crossref
Kathrin M. Bernt, Aram Prokop, Nicole Huebener, Gerhard Gaedicke, Wolfgang Wrasidlo & Holger N. Lode. (2009) Eradication of CD19 + Leukemia by Targeted Calicheamicin θ . Bioconjugate Chemistry 20:8, pages 1587-1594.
Crossref
Ivana Gojo. (2008) Improving treatment strategies for acute lymphoblastic leukemia by combining immunotherapy and chemotherapy. Leukemia Research 32:6, pages 847-849.
Crossref
Jeanann L. Suggs, Julius M. Cruse & Robert E. Lewis. (2007) Aberrant myeloid marker expression in precursor B-cell and T-cell leukemias. Experimental and Molecular Pathology 83:3, pages 471-473.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.